Using data from 4691 participants age 65 and older from the European Eye Study, researchers determined overall risk of AMD and aspirin-related risk. They found AMD was present in 36.4 percent of all participants and late AMD was present in 3.3 percent. Monthly aspirin use was reported by 41.2 percent, weekly aspirin use by 7 percent and daily use by 17.3 percent. Odds ratios were increased for aspirin users: 1.26 for grade 1 disease, 1.42 for grade 2 and 2.22 for wet late AMD.
Related Articles on Ophthalmology:
Dr. Nancy E. Cline Becomes Partner of Shelby Eye Centers
Yale Ophthalmologist Dr. Jimmy K. Lee Joins NVISION Laser Eye Centers
5 Recent Research Findings on Glaucoma
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
